Mihalcea Ana-Raluca, Garnier Nathalie, Faure-Conter Cécile, Rama Nicolas, Renard Cécile, Benezech Sarah, Bertrand Yves, Fuhrmann Christine, Domenech Carine
Institute of Pediatric Hematology and Oncology (IHOPe), 69008 Lyon, France.
Hospices Civils de Lyon, 69002 Lyon, France.
Cancers (Basel). 2023 Feb 2;15(3):938. doi: 10.3390/cancers15030938.
Documenting bacteremia at the onset of fever in immunosuppressed children is challenging; therefore, it leads to the early administration of broad-spectrum antibiotics. We aimed to analyse the evolution of antibiotic resistance profiles of bacterial bloodstream infections (BSI) and gut colonisations in a large cohort of immunocompromised children carrying a central venous catheter, in comparison with a prior, similar study conducted in our centre from 2014 to 2017. A retrospective, observational cohort study was conducted from January 2018 to December 2021, in a tertiary centre for paediatric immuno-haematology and oncology. Empirical antibiotic therapy was adapted to the immunosuppression risk group and prior bacterial colonisation. There was a mean of 6.9 BSI/1000 patient bed days. Multidrug-resistant bacteria (MDRB) associated BSI accounted for 35/273 (12.8%). The incidence of MDRB gum/gut colonisation and MDRB associated BSI increased annually and correlated with the level of immunosuppression ( = 0.024). One third (34.7%) of the BSI episodes were not associated with neutropenia. As compared to the previous study, an alarming emergence of MDRB responsible for gut colonisations and BSI in immunosuppressed children was reported over the last four years. The degree of immunosuppression directly correlates with the risk of having an MDRB gut colonisation or MDRB BSI.
记录免疫抑制儿童发热开始时的菌血症具有挑战性;因此,这导致了广谱抗生素的早期使用。我们旨在分析一大群携带中心静脉导管的免疫受损儿童中细菌性血流感染(BSI)和肠道定植的抗生素耐药谱的演变,并与我们中心在2014年至2017年进行的一项先前类似研究进行比较。2018年1月至2021年12月,在一家儿科免疫血液学和肿瘤学三级中心进行了一项回顾性观察队列研究。经验性抗生素治疗根据免疫抑制风险组和先前的细菌定植情况进行调整。平均每1000个患者住院日有6.9例BSI。多重耐药菌(MDRB)相关的BSI占273例中的35例(12.8%)。MDRB牙龈/肠道定植和MDRB相关BSI的发生率逐年上升,且与免疫抑制水平相关( = 0.024)。三分之一(34.7%)的BSI发作与中性粒细胞减少无关。与先前的研究相比,报告称在过去四年中,免疫抑制儿童中导致肠道定植和BSI的MDRB出现令人担忧。免疫抑制程度与发生MDRB肠道定植或MDRB BSI的风险直接相关。